2024
Intravenous administration of fibrinolytic drugs, such as recombinant tissue plasminogen activator (rtPA) is the standard treatment of acute thrombotic diseases. (…)
Consulter 
2023
Tomographic perfusion imaging techniques are integral to translational stroke research paradigms that advance our understanding of the disease. Functional ultrasound (…)
Consulter
2023
Systemic injection of thrombolytic drugs is the gold standard treatment for non-invasive blood clot resolution. The most serious risks associated (…)
Consulter
2023
Although dementia research has been dominated by Alzheimer’s disease (AD), most dementia in older people is now recognised to be (…)
Consulter
2023
Sleep, especially slow wave sleep (SWS), is essential for cognitive functioning and is reduced in aging. The impact of sleep (…)
Consulter
2023
"Distal anterior cerebral aneurysm" (DACA) represents 4% of intracranial aneurysms. Two treatment modalities are available, microsurgery and endovascular therapy (EVT).
Consulter
